Results for tag: "Hepatorenal"

The Hepatorenal market is a subset of the larger Hepatology field, which focuses on the diagnosis and treatment of diseases related to the liver, gallbladder, biliary tree, and pancreas. It specifically deals with the diagnosis and treatment of kidney diseases associated with liver diseases, such as cirrhosis, hepatitis, and fatty liver disease. Treatment options for these conditions include medications, lifestyle changes, and in some cases, surgery. The Hepatorenal market is composed of a variety of companies, including pharmaceutical companies, medical device manufacturers, and healthcare providers. Pharmaceutical companies develop and market drugs to treat liver and kidney diseases, while medical device manufacturers produce and distribute devices used in the diagnosis and treatment of these conditions. Healthcare providers, such as hospitals and clinics, provide diagnosis and treatment services for patients with liver and kidney diseases. Notable companies in the Hepatorenal market include AbbVie, Gilead Sciences, Merck & Co., Novartis, Pfizer, and Roche. Show Less Read more